Investing Profile

Omri Amirav Drory(1710)

InvestorVCFounder
Head of NFX Bio at NFX
nfx.com/bio/San Francisco Bay Area
Photo of Omri Amirav Drory, General Partner at NFX

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture
Picture

54 Investors

Connected to James Currier (NFX), Gigi Levy-Weiss (NFX), Pete Flint (NFX), and 51 other investors on Signal.

Stanford University Network
532 CONNECTIONS
Stanford University Network
99 CONNECTIONS
Tel Aviv University Network
82 CONNECTIONS
Tel Aviv University Network
82 CONNECTIONS
Tel Aviv University Network
82 CONNECTIONS
cb
NFX General Partner
$500K - $5.0M
$3.0M
9
$450M
CompanyStageDateRound SizeTotal Raised
Talus Bio
SeedNov 2021
Co-investors: Dave Messina (Pioneer Fund), Milad Alucozai (BoxOne Ventures)
La Jolla Labs
SeedOct 2021
Mana Bio
SeedOct 2021
Gilboa Therapeutics
Seed RoundSep 2021
Seed RoundJan 2021
Psyga
Seed RoundJun 2021
EdiTy Therapeutics
Seed RoundMay 2021
Co-investors: Sharon Azulai
NanoCarry
Seed RoundFeb 2021
Pepper Bio
Pre Seed RoundFeb 2021
Co-investors: Eric Brook (B Capital Group), Kunal Sethi (Prithvi Ventures), Martin Alexander Gershon (Endeavor Venture Funds)
Board Member Cyclana Bio2025 - Present
Board Member ImmuneBridge2025 - Present
Board Member Powerhouse Biology2025 - Present
Board Member Permanence Bio2025 - Present
Board Member Radar Therapeutics2024 - Present
Board Member TwoStep Therapeutics2024 - Present
Board Member ZipBio2023 - Present
Board Member Centivax2022 - Present
Founder & chairman of the board RenewalBio2022 - Present
Founder & CEO Renewal Bio2022 - Present
Board Member Pumpkinseed2022 - Present
Board Member Talus Bio2021 - Present
Board Member Mana.bio2021 - Present
Board Member C2i Genomics2021 - Present
Board Member CANNASOUL GROUP2021 - Present
Board Member PANGEA Therapeutics2021 - Present
Board Member Pangea Therapeutics2021 - Present
Board Member Nanocarry Therapeutics2021 - Present
Board Member NanoCarry2021 - Present
Board Member Celata Bioinnovations2021 - Present
Board Member Gilboa Therapeutics2021 - Present
General Partner NFX2020 - Present
General Partner NF Forward2020 - Present
Head of NFX Bio NFX2020 - Present
Board Member Eleven Therapeutics2020 - Present
Board Member Edity Therapeutics2020 - Present
Board Member EdiTy Therapeutics 2020 - Present
Board Member EdiTy Therapeutics2020 - Present
Advisor Immunai2020 - Present
Board Member Light Bio2020 - Present
Board Member Light Bio, Inc.2020 - Present
Board Member Light Bio Inc2020 - Present
Member 8400 The Health Network2020 - Present
Member 8400 - The Health Network2020 - Present
Board Member Armada Biosystems2019 - Present
Board Member Wild Biotech2019 - Present
Mentor AGE12019 - Present
Founding Partner tech.bio2018 - Present
Advisor Mammoth Biosciences2016 - Present
Advisor Mammoth Biosciences2016 - Present
Mentor Loop Genomics2015 - Present
Mentor SOSV SF & NY (Formerly IndieBio)2015 - Present
Mentor IndieBio2015 - Present
Board Member La Jolla Labs Inc.2021 - 2026
Board Member Pangea Biomed2021 - 2026
Board Member Pepper Bio2021 - 2025
Board Member resistanceBio2022 - 2024
Board Observer C2i Genomics2019 - 2024
Mentor age12019 - 2023
Advisor Element Biosciences2015 - 2022
Head of Corporate Development Twist Bioscience2016 - 2018
Israeli Community Ambassador Singularity University2015 - 2016
Founder & CEO Genome Compiler Corp.2011 - 2016
Founder & CEO Genome Compiler2011 - 2016
Postdoctoral associate Stanford Center for Clinical Research (SCCR)2007 - 2011
Postdoctoral associate Stanford University2007 - 2011
Attendee Singularity University2011 - 2011
attendee Singularity University2011 - 2011
Stanford University Postdoctoral , Biochemistry and Molecular Biology Biochemistry and Molecular Biology
Tel Aviv University Doctor of Philosophy (Ph.D.) Biochemistry
Tel Aviv University Bachelor of Science - BS Biochemistry and Molecular Biology
Stanford University School of Medicine Postdoc Neuroscience
Tel Aviv University Ph.D. biochemistry